The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Janssen Diagnostics
Consulting or Advisory Role - Janssen Diagnostics
Circulating tumor cells (CTC) and pathological complete response (pCR) as independent prognostic factors in inflammatory breast cancer (IBC) in a pooled analysis of two multicentre phase II trials (BEVERLY 1 & 2) of neoadjuvant chemotherapy combined with bevacizumab.
 
Jean-Yves Pierga
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Janssen Diagnostics; Novartis; Roche Pharma AG
Research Funding - Janssen Diagnostics (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Francois-Clement Bidard
No Relationships to Disclose
 
Aurelie Autret
No Relationships to Disclose
 
Thierry Petit
No Relationships to Disclose
 
Fabrice Andre
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Novartis
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche
 
Florence Dalenc
No Relationships to Disclose
 
Christelle Levy
No Relationships to Disclose
 
Jean-Marc Ferrero
No Relationships to Disclose
 
Gilles Romieu
No Relationships to Disclose
 
Jacques Bonneterre
No Relationships to Disclose
 
Florence Lerebours
No Relationships to Disclose
 
Thomas Denis Bachelot
No Relationships to Disclose
 
Pierre Kerbrat
No Relationships to Disclose
 
Emmanuelle Charafe-Jaufret
No Relationships to Disclose
 
Jérôme Lemonnier
No Relationships to Disclose
 
Patrice Viens
Research Funding - Roche/Genentech (Inst)